Name | Number of supported studies | Average coverage | |
---|---|---|---|
enterocyte | 6 studies | 36% ± 8% | |
epithelial cell of proximal tubule | 3 studies | 16% ± 1% |
Insufficient scRNA-seq data for expression of SLC6A19 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 100% | 5970.89 | 89 / 89 | 50% | 25.63 | 450 / 901 |
stomach | 75% | 89.66 | 270 / 359 | 37% | 12.89 | 105 / 286 |
liver | 95% | 128.69 | 215 / 226 | 13% | 4.57 | 52 / 406 |
pancreas | 85% | 53.94 | 280 / 328 | 21% | 5.24 | 38 / 178 |
intestine | 61% | 5251.82 | 585 / 966 | 21% | 4.24 | 113 / 527 |
prostate | 55% | 194.88 | 134 / 245 | 8% | 4.09 | 40 / 502 |
peripheral blood | 35% | 53.20 | 325 / 929 | 0% | 0 | 0 / 0 |
esophagus | 3% | 8.11 | 47 / 1445 | 29% | 10.46 | 53 / 183 |
spleen | 16% | 9.79 | 39 / 241 | 0% | 0 | 0 / 0 |
lung | 4% | 1.59 | 25 / 578 | 7% | 1.54 | 80 / 1155 |
adrenal gland | 3% | 0.42 | 7 / 258 | 2% | 0.07 | 5 / 230 |
breast | 4% | 2.17 | 20 / 459 | 0% | 0 | 0 / 1118 |
bladder | 0% | 0 | 0 / 21 | 4% | 0.35 | 20 / 504 |
adipose | 4% | 1.26 | 43 / 1204 | 0% | 0 | 0 / 0 |
uterus | 2% | 2.82 | 4 / 170 | 1% | 0.14 | 5 / 459 |
ovary | 3% | 1.50 | 5 / 180 | 0% | 0 | 0 / 430 |
thymus | 3% | 0.51 | 17 / 653 | 0% | 0 | 0 / 605 |
skin | 1% | 0.63 | 26 / 1809 | 0% | 0.01 | 1 / 472 |
blood vessel | 2% | 0.44 | 22 / 1335 | 0% | 0 | 0 / 0 |
muscle | 1% | 0.23 | 11 / 803 | 0% | 0 | 0 / 0 |
heart | 1% | 0.19 | 11 / 861 | 0% | 0 | 0 / 0 |
brain | 1% | 0.19 | 19 / 2642 | 0% | 0 | 0 / 705 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007584 | Biological process | response to nutrient |
GO_0006865 | Biological process | amino acid transport |
GO_0015804 | Biological process | neutral amino acid transport |
GO_0035725 | Biological process | sodium ion transmembrane transport |
GO_0019058 | Biological process | viral life cycle |
GO_0003333 | Biological process | amino acid transmembrane transport |
GO_0031526 | Cellular component | brush border membrane |
GO_0016324 | Cellular component | apical plasma membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005886 | Cellular component | plasma membrane |
GO_0015175 | Molecular function | neutral L-amino acid transmembrane transporter activity |
GO_0015293 | Molecular function | symporter activity |
GO_0015171 | Molecular function | amino acid transmembrane transporter activity |
GO_0005515 | Molecular function | protein binding |
Gene name | SLC6A19 |
Protein name | Transporter Alternative protein SLC6A19 Sodium-dependent neutral amino acid transporter B(0)AT1 (Solute carrier family 6 member 19) (System B(0) neutral amino acid transporter AT1) |
Synonyms | B0AT1 |
Description | FUNCTION: Transporter that mediates resorption of neutral amino acids across the apical membrane of renal and intestinal epithelial cells . This uptake is sodium-dependent and chloride-independent . Requires CLTRN in kidney or ACE2 in intestine for cell surface expression and amino acid transporter activity . . |
Accessions | Q695T7 L8E8F7 ENST00000304460.11 E9PD72 ENST00000515652.5 |